ReaGenics

Reagenics is a biotechnology startup based in Israel, founded in 2019. The company specializes in plant molecular harvesting, utilizing bioreactors for the production of molecular compounds. With a strong focus on cell tissue culturing, Reagenics aims to establish itself as a frontrunner in the production of pharmaceutical, medical, and wellness products. With its innovative technology platform, the company is poised to make significant strides in the biotechnology industry. As of now, no specific details regarding last investment and last investment investors are available for Reagenics. However, considering the potential for disruption in the biotechnology sector and the innovative approach of the company, Reagenics could be an attractive prospect for venture capital firms looking to invest in groundbreaking technologies. With its promising vision and location in a hub of technological innovation, Reagenics presents an intriguing opportunity for investors seeking to capitalize on advancements in biotechnology.